DOC

REITs are poised for 6-7% earnings growth in coming years, outpacing the historical 3-4% average, with multiple sectors showing accelerating fundamentals. Shopping centers, healthcare (notably senior housing), and data centers are standout sectors, benefiting from robust private market demand, supply constraints, and AI-driven tailwinds. Office REITs see improving leasing, especially from AI-related demand, while quality bifurcation widens; overweight positions in BXP and CUZ reflect this thesis.

Income investors entering July 2026 are getting a friendlier setup than they had six months ago.

DOC surges 28% in three months as leasing, occupancy gains and Janus Living growth support its shift toward labs and outpatient assets.

Healthpeak Properties remains a Strong Buy, combining value, income, and recovery potential in healthcare real estate. DOC's outpatient medical and life sciences segments show improving occupancy, strong lease spreads, and embedded rent escalators supporting steady growth. The Janus Living spin-off unlocks value in senior housing, with DOC retaining 82% ownership and benefiting from high segment growth.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. ("Healthpeak") (NYSE: DOC) announced today the release of its 15th annual 2025 Corporate Impact Report (the "Report"). The Report highlights Healthpeak's continued focus on building a resilient portfolio, advancing sustainability goals, fostering a workplace culture guided by its WE CARE core values, and promoting sound corporate governance and transparency. "As one of the nation's leading owners of Outpatient Medical, Lab, and Senior Housing.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report second quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, August 4, 2026. Healthpeak will host a conference call and webcast on Wednesday, August 5, 2026 at 10:00 a.m. Eastern Time to review its financial performance and operating results. The conference call can b.

Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?

DOC gains 22.7% year-to-date, driven by leasing momentum, rising occupancy and Janus Living growth.

Healthpeak Properties earns a buy rating, driven by strong capital allocation and a compelling portfolio mix across Outpatient Medical, Labs, and Senior Housing. DOC trades at ~11x P/FFO with a >6% dividend yield, offering both stability and upside from secular and cyclical trends in its segments. Recent moves—like the Janus Living IPO, opportunistic acquisitions, and disciplined share buybacks—unlock value and enhance capital efficiency.

Healthpeak Properties is still a Buy after the recent rally, supported by strong earnings, a robust dividend, and significant re-rating potential. DOC's Q1 2026 beat on FFO and revenue; completed the Janus Living IPO; and executed major acquisitions, reinforcing portfolio value and future growth prospects. With $1.17 billion in cash and a sustainable 6.2% monthly dividend yield (~70.7% payout ratio), DOC's dividend looks safe despite macroeconomic headwinds, leaving room for more buybacks.